NEWSROOM | Galderma

Two patients, one condition: the overlooked impact of atopic dermatitis on families

Galderma delivers record net sales of 3.737 billion USD in the first nine months of 2025 and 15.0% year-on-year growth at constant currency, raises full-year guidance

AMWC Dubai 2025: Galderma’s Scientific Presentations

AMWC Dubai: Galderma demonstrates Injectable Aesthetics leadership through updates on its scientific innovations and community education

Galderma launches transformative skincare segment with Cetaphil’s new Skin Activator Hydrating & Firming Line, in partnership with actor and filmmaker Mariska Hargitay

Galderma’s groundbreaking real-world study reveals the biological toll of modern living and urban environments on sensitive skin

EADV 2025: Galderma reinforces leadership in dermatology with latest advances in sensitive skin and itch

Galderma launches Alastin® in China, supporting the skin’s natural regenerative abilities in a rapidly expanding market

EADV 2025: scientific presentations supported by Galderma

Advancing the future of dermatology with robust IT

Galderma introduces Cetaphil Nourishing Oil to Foam Cleanser, a breakthrough in hydrating cleansing for sensitive skin

10 years of GAIN: inspiring aesthetic education and excellence

Galderma delivers record first half 2025 net sales of 2.448 billion USD and 12.2% year-on-year growth at constant currency, raises full-year top-line guidance